Lowering of AGE and C-reactive protein, raising of sRAGE, anduse of antioxidants may be considered as an adjunct therapy besides lipidlowering agents for the treatment of hypercholesterolemia. This evidence concerns the gene CRP and familial hypercholesterolemia.